Table 1 Correlation of AURKA expression and clinicopathologic characteristics of PBC in the datasheet of GSE 13507
From: Increased AURKA promotes cell proliferation and predicts poor prognosis in bladder cancer
Characteristic | n | AURKA expression (%) | Pearson χ2 | P | |
|---|---|---|---|---|---|
High | Low or no | ||||
Total | 165 | 30 (18.18) | 135 (81.82) | Â | Â |
Age | Â | Â | Â | 3.460 | 0.069 |
 ≥ 65 | 96 | 22 (22.92) | 74 (77.08) |  |  |
 < 65 | 69 | 8 (11.59) | 61 (88.41) |  |  |
Gender | Â | Â | Â | 1.774 | 0.196 |
 Female | 30 | 8 (26.67) | 22 (73.33) |  |  |
 Male | 135 | 22 (16.30) | 113 (83.70) |  |  |
Tumor stage | Â | Â | Â | 11.815 | 0.019* |
 Ta | 24 | 3 (12.50) | 21 (87.50) |  |  |
 T1 | 80 | 8 (10.00) | 72 (90.00) |  |  |
 T2a + T2b | 31 | 11 (35.48) | 20 (64.52) |  |  |
 T3a + T3b | 19 | 5 (26.31) | 14 (73.69) |  |  |
 T4a + T4b | 11 | 3 (27.27) | 8 (72.73) |  |  |
Grade | Â | Â | Â | 17.927 | 0.000** |
 low | 105 | 9 (8.57) | 96 (91.43) |  |  |
 high | 60 | 21 (35.00) | 39 (65.00) |  |  |
Invasiveness | Â | Â | Â | 13.229 | 0.001** |
 superical | 103 | 10 (9.71) | 93 (90.29) |  |  |
 invasive | 62 | 20 (32.26) | 42 (67.74) |  |  |
Systemic chemo | Â | Â | Â | 0.002 | 1.000 |
 Yes | 27 | 5 (18.52) | 22 (81.48) |  |  |
 No | 138 | 25 (18.11) | 113 (81.89) |  |  |
Lymph node status | Â | Â | Â | 5.035 | 0.184 |
 Nx | 1 | 0 (0.00) | 1 (100.00) |  |  |
 N0 | 149 | 26 (17.45) | 123 (82.55) |  |  |
 N1 | 8 | 2 (25.00) | 6 (75.00) |  |  |
 N2 | 6 | 1 (16.67) | 5 (83.33) |  |  |
 N3 | 1 | 1 (100.00) | 0 (0.00) |  |  |
Progression | Â | Â | Â | 1.492 | 0.299 |
 No | 134 | 22 (16.42) | 112 (83.58) |  |  |
 Yes | 31 | 8 (25.81) | 23 (74.19) |  |  |
Metastasis | Â | Â | Â | 0.075 | 1.000 |
 No | 158 | 29 (18.35) | 129 (81.65) |  |  |
 Yes | 7 | 1 (14.28) | 6 (85.72) |  |  |
Cancer-specific survival | Â | Â | Â | 4.557 | 0.042* |
 Survival | 133 | 20 (15.04) | 113 (84.96) |  |  |
 Death | 32 | 10 (31.25) | 22 (68.75) |  |  |